These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6453644)

  • 21. Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanoma.
    Samson MK; Baker LH; Cummings G; Talley RW; McDonald B; Bhathena DB
    Cancer Treat Rep; 1982 Feb; 66(2):371-3. PubMed ID: 6459845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chlorozotocin treatment of advanced gastrointestinal cancer.
    Veronesi A; Magri MD; Tirelli U; Galligioni E; Figoli F; Zagonel V; Tumolo S; Grigoletto E
    Med Pediatr Oncol; 1983; 11(5):365-6. PubMed ID: 6226856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinogenic activity in Sprague-Dawley rats of 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-gluco-pyranose (chlorozotocin).
    Habs M; Eisenbrand G; Schmähl D
    Cancer Lett; 1979 Dec; 8(2):133-7. PubMed ID: 162366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytostatic agent induced lung disease].
    Obrist R; Obrecht JP
    Dtsch Med Wochenschr; 1978 May; 103(18):765-6. PubMed ID: 77216
    [No Abstract]   [Full Text] [Related]  

  • 25. [Respiratory failure and pulmonary fibrosis as a late side-effect after chemotherapy-induced by oxygen administration].
    Grahmann PR; Brauer M; Hüter L; Sayer H; Neumann R; Braun RK
    Pneumologie; 2005 Nov; 59(11):763-9. PubMed ID: 16385437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pulmonary accidents following treatments with immunodepressive agents].
    Coury C; Saltiel JC
    Rev Prat; 1972 Jan; 22(3):319-28. PubMed ID: 5029700
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase II trial with chlorozotocin in advanced colorectal cancer.
    Bleiberg H; Rozencweig M; Michel J; Clavel M; Longeval E; Feremans W; Bondue H; Lardinois J; Crespeigne N; Kenis Y
    Eur J Cancer Clin Oncol; 1981 Aug; 17(8):863-6. PubMed ID: 6459936
    [No Abstract]   [Full Text] [Related]  

  • 28. Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer.
    Maitland ML; Wilcox R; Hogarth DK; Desai AA; Caligiuri P; Abrahams C; Salgia R
    Lung Cancer; 2006 Nov; 54(2):243-5. PubMed ID: 16949700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitrosourea chemotherapeutic agents: Chlorozotocin.
    National Toxicology Program
    Rep Carcinog; 2011; 12():328-9. PubMed ID: 21860521
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug-induced interstitial lung diseases.
    Gockerman JP
    Clin Chest Med; 1982 Sep; 3(3):521-36. PubMed ID: 6751669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial lymphoid interstitial pneumonia: a long-term follow-up.
    O'Brodovich HM; Moser MM; Lu L
    Pediatrics; 1980 Mar; 65(3):523-8. PubMed ID: 7360539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlorozotocin: phase II evaluation in patients with advanced sarcomas.
    Sordillo PP; Magill GB; Gralla RJ
    Cancer Treat Rep; 1981; 65(5-6):513-4. PubMed ID: 6453647
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug induced lung disease.
    Pannier R
    Eur J Respir Dis Suppl; 1983; 126():151-6. PubMed ID: 6144563
    [No Abstract]   [Full Text] [Related]  

  • 34. A phase II study of chlorozotocin in metastatic malignant melanoma.
    Hoth DF; Schein PS; Winokur S; Woolley PV; Robichaud K; Binder RB; Smith FP
    Cancer; 1980 Oct; 46(7):1544-7. PubMed ID: 6448088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [One hundred and twenty-four cases of diffuse pulmonary disease diagnosed by transbronchial lung biopsy via fiberbronchoscope].
    Zhu L; Zhou H; Chen P; Liu Z
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(6):575-6. PubMed ID: 12080726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Radiation- and chemically-induced respiratory manifestations].
    Quoix E; Mornex F; Milleron B; Pauli G
    Rev Mal Respir; 1997 Nov; 14(5):341-53. PubMed ID: 9480478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II evaluation of chlorozotocin in refractory multiple myeloma.
    Forman WB; Cohen HJ; Bartolucci AA; Manning G
    Cancer Treat Rep; 1984 Nov; 68(11):1409-10. PubMed ID: 6238673
    [No Abstract]   [Full Text] [Related]  

  • 38. The nitrosoureas and pulmonary toxicity.
    Weiss RB; Poster DS; Penta JS
    Cancer Treat Rev; 1981 Jun; 8(2):111-25. PubMed ID: 6454489
    [No Abstract]   [Full Text] [Related]  

  • 39. [Disturbances of pulmonary function and biopsy findings with special reference to open lung biospy of diffuse lung diseases].
    Masaki M; Matsui A; Homma A; Onoue M; Koguchi N
    Naika; 1968 Jun; 21(6):1046-60. PubMed ID: 5704150
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II study of chlorozotocin in advanced breast cancer.
    Edmonson JH; Green SJ; Ingle JN; Ahmann DL; Disel HF; Creagan ET
    Cancer Treat Rep; 1981; 65(5-6):537-8. PubMed ID: 6453648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.